Search results
Cambridge MP backs clean energy push to cut bills and boost energy security
The Labour MP for Cambridge, Daniel Zeichner, is backing new measures to ramp up this government’s clean energy mission and protect family budgets from shocks on the global stage.
ARU staff recognised for boosting employability
Alessia Mevoli, Scott Steele and Asma Rezaei are shortlisted for national awards.
How do young people in UK view healthy ageing?
ARU launches unique research project, in partnership with Hallmark Foundation.
Cambridge report finds AI integration gap and risks in financial services
Key findings of ‘2026 Global AI in Financial Services Report – Adoption, Impact and Risks’:
Teenage boys build friendships and confidence at fun-filled Young People’s Day at Milton Hospice
“It’s wonderful to see them building friendships, gaining confidence and simply enjoying being teenagers together. We had so much fun” – teamwork, clue-solving, singing and dancing are among the highlights of a boys’ day at Milton
National playoff success for ARU’s basketball stars
Anglia Ruskin’s women’s basketball team achieve surprise win over London Cavaliers.
EpilepsyGTx appoints Professor Dimitri Kullmann as Chief Scientific Officer
Appointment of UCL Neurologist will accelerate the delivery of novel gene therapies for refractory epilepsy
Isogenica Ltd. and Axxam S.p.A. Announce Collaboration to Provide Unique VHH Antibody Discovery Solutions
Axxam S.p.A. and Isogenica Ltd. have announced a partnership to bring together functional bioassay capabilities with unique antibody discovery solutions for biotechnology and pharmaceutical clients.
Isogenica and Cube Biotech Unite to Accelerate GPCR Therapeutics
Isogenica, a global leader in synthetic VHH antibody discovery, has announced a strategic collaboration with Cube Biotech, experts in stabilised protein technologies, to tackle one of the most complex challenges in drug discovery: G protein-coupled receptors (GPCRs).
From Hit to Clinic: Isogenica and Charles River Collaborate to Accelerate Next-Generation Peptide and VHH Discovery
Every breakthrough begins with discovery. Isogenica, a leader in synthetic VHH antibody and peptide discovery, has announced a collaboration with Charles River, a leading, global provider of drug discovery, development, and manufacturing solutions, to help biotech companies streamline discovery and accelerate progress toward clinic-ready therapeutics. This collaboration unites Isogenica’s…
Cerberus Therapeutics Enters into Antibody Discovery Agreement with Isogenica to Advance Immune-Modulating Therapies
Isogenica Ltd., The VHH Company™, today announced an antibody discovery agreement with Cerberus Therapeutics to support the development of targeted immune-modulating therapies using single-domain antibodies. This agreement brings together Cerberus’s KappaLink™ platform — designed to engage Fc receptor-positive (FcR+) effector cells via circulating immunoglobulins — with Isogenica’s expertise…
AI in antibody discovery: Why better data still matters
AI and machine learning are becoming increasingly important in antibody discovery, but the field is moving beyond the idea that computational tools will simply replace experimental science.
Crossing the blood–brain barrier: Why VHHs matter for CNS Biologics
The blood–brain barrier (BBB) remains one of the hardest challenges in biologics development.
Beyond liver uptake: How VHHs could support more targeted LNP delivery
Lipid nanoparticles have become one of the most important delivery platforms for next-generation therapeutics, particularly for payloads such as mRNA, siRNA and oligonucleotides.
It’s time to govern your team’s AI use
Do you know which AI tools your team is using at work… and what they’re putting into them?
Most senior leaders we speak to think they do. Until we dig a little deeper.
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers
New PTC Harmony Thermal Cycler Line Expands Access to Reliable, High-Performance PCR Across Academic and Biopharma Laboratories
Webinar: When Hits Don’t Translate – Challenging Membrane Targets from GPCRs to CD3–TCR
How target presentation and environment shape epitope access, selection outcomes, and functional screening.
Leading Social Housing team planning for further growth
One of the region’s leading Social Housing legal teams is targeting further expansion as demand for its services from housing associations, local authorities and housebuilder clients continues to grow.
Acteon's new-look website speaks to common challenges in the world of work
From AI adoption to L&D that drives business results, Acteon's refreshed site shows how a behavioural, human-centred approach can turn today's toughest challenges into real change.
Career Clinic Cambridge: events and clinics
A collaborative initiative offering career‑focused events, clinics and facilitated conversations to support clarity, reflection and practical next steps.
Event Hosting & Collaborative Experiences
Facilitation and hosting for events, meetings and gatherings, helping sessions flow smoothly and stay engaging.
1:1 Support for Professionals
One‑to‑one support for busy professionals to find clarity, build momentum and navigate work‑life challenges.
Organisational Alignment & Ways of Working
Support for organisations and teams to align goals, improve ways of working, and navigate complexity more effectively.
Workshops & Facilitation
Interactive workshops and facilitated sessions to support clarity, collaboration and progress for teams and groups.